Trump nominates White House aide Heidi Overton to lead FDA amid controversy
President Donald Trump has selected Dr. Heidi Overton, a White House domestic policy aide and physician, to lead the U.S. Food and Drug Administration (FDA). If confirmed by the Senate, Overton would replace Marty Makary, who resigned after clashes with the administration. The nomination faces strong bipartisan criticism, particularly from Republican senators over her role in vaccine policy and conservative health stances. The FDA has lost over 3,000 staff and faces trust and politicization challenges.
Editorial responsibility
- No named human review is recorded for this page.
- Reports are grouped by semantic similarity and deterministic rules. Language models may assist titles, summaries, translation and cross-source analysis; the page itself is projected from evidence records.
- Current automated evidence projection
Cross-source coverage
Wire timeline
Trump's FDA Nominee Heidi Overton Faces Senate Confirmation Hurdles
President Donald Trump's nominee to lead the Food and Drug Administration, Dr. Heidi Overton, faces significant challenges in securing Senate confirmation. Sen. Bill Cassidy, R-La., chairman of the Senate Health, Education, Labor and Pensions Committee, expressed serious doubts about Overton's nomination, citing her lack of managerial experience and her role in a controversial Health and Human Services executive order that would weaken vaccine requirements. Cassidy stated that Overton's involvement in the vaccine order 'calls into question her commitment to standing up for sound science and protecting children's health' and called it 'almost disqualifying.' The White House defended Overton, highlighting her experience as Deputy Assistant to the President for Domestic Policy and her role coordinating interagency policymaking on Trump's MAHA agenda. The confirmation process is uncertain, with Cassidy controlling whether to schedule a hearing or committee vote. The White House has previously had to withdraw other nominees, including surgeon general nominee Dr. Casey Means, when they lacked sufficient votes.
Trump's FDA Nominee Heidi Overton Faces Senate Confirmation Hurdles
President Donald Trump's nominee to lead the Food and Drug Administration, Dr. Heidi Overton, faces significant challenges in securing Senate confirmation. Senator Bill Cassidy, the Republican chairman of the Senate Health, Education, Labor and Pensions Committee, expressed serious doubts about Overton's qualifications, citing her lack of managerial experience and her role in a controversial Health and Human Services Department executive order that would weaken vaccine requirements. Cassidy described the vaccine order as 'nonsensical' and 'almost disqualifying.' The White House is pushing for Overton's confirmation, highlighting her experience as Deputy Assistant to the President for Domestic Policy and her role in coordinating the MAHA agenda across multiple agencies. However, the administration has previously had to withdraw other nominees, including surgeon general nominee Dr. Casey Means, due to lack of committee support. Trump defended Overton as 'smart and respected by all' in a social media post.
Trump's FDA Nominee Heidi Overton Faces Senate Confirmation Hurdles
Dr. Heidi Overton, President Trump's nominee to lead the Food and Drug Administration, faces significant opposition from Senate HELP Committee Chairman Bill Cassidy. Cassidy publicly questioned Overton's managerial experience and her role in a recent HHS executive order that would weaken vaccine requirements, calling the order 'nonsensical' and suggesting it could be 'almost disqualifying.' The White House is pushing for her confirmation, highlighting her work coordinating interagency policy on Trump's MAHA agenda and her credentials as a board-certified physician with a PhD from Johns Hopkins. Cassidy, who previously expressed doubts about HHS Secretary RFK Jr. and CDC Director Schwartz before voting to confirm them, holds the key to scheduling a hearing. The article notes the White House has previously withdrawn other nominees, including surgeon general picks Dr. Casey Means and Janette Nesheiwat, when confirmation appeared unlikely.
Show 8 older updatesHide older updates
Trump Names Heidi Overton as FDA Pick; Democrats Call Her 'Anti-Abortion Extremist'
President Donald Trump announced the nomination of Dr. Heidi Overton, a White House aide and deputy director of the Domestic Policy Council, to lead the Food and Drug Administration. Overton, a medical doctor and former chief policy officer at the America First Policy Institute, has been a key figure in Trump's second-term health initiatives, including efforts to lower drug prices and a controversial order to split the MMR vaccine. She has been critical of abortion pills, and if confirmed, could roll back FDA rules that expanded access to mifepristone. Democratic Senator Patty Murray called her a 'far-right, anti-abortion extremist,' while Republican Senator Bill Cassidy expressed 'strong concerns' over her lack of managerial experience and involvement in the vaccine order. Overton would replace Dr. Marty Makary, who resigned in May, leaving behind unfinished work on ultraprocessed foods, antidepressants, and COVID-19 shots. The nomination faces a narrowly Republican-led Senate and must pass the Health, Education, Labor, and Pensions Committee.
Trump Selects White House Aide Heidi Overton as FDA Commissioner Nominee
President Donald Trump has selected Heidi Overton, a White House aide, to be his nominee for Commissioner of the Food and Drug Administration (FDA). The announcement has drawn immediate and strong criticism from key Republican senators, including Senate Health Committee Chairman Bill Cassidy. Cassidy stated that Overton's role in a vaccine-related executive order is 'almost disqualifying,' expressing serious reservations about her nomination. The New York Times and The Hill report that the nomination faces significant hurdles in the Senate confirmation process due to bipartisan concerns over her qualifications and policy stances. The Washington Post and Axios also confirmed the selection, highlighting the contentious nature of the pick.
Trump picks Dr. Heidi Overton, a top White House aide, to lead the Food and Drug Administration
President Donald Trump has selected Dr. Heidi Overton, a top White House aide, to lead the Food and Drug Administration (FDA). The nomination has drawn immediate criticism from key Republican senators. Senate Health Panel Chairman expressed strong reservations about Overton, and Senator Cassidy criticized her role in a vaccine-related order, calling it 'almost disqualifying'. The selection signals a potential shift in FDA policy direction and is expected to face a contentious confirmation process.
Trump to Nominate Heidi Overton to Lead the FDA
President Donald Trump is expected to nominate Dr. Heidi Overton, a top White House policy aide and physician, to serve as the next commissioner of the U.S. Food and Drug Administration (FDA). Overton, who has been a key health policy advisor in the Trump administration, is noted for her opposition to abortion. The nomination has been reported by multiple major news outlets including NBC News, AP News, The Guardian, CBS News, and CNN. If confirmed, Overton would lead the agency responsible for regulating food safety, pharmaceuticals, medical devices, and tobacco products. Her nomination signals a continued focus on conservative health policy priorities within the administration.
Trump picks White House adviser Overton to head FDA
President Donald Trump announced he will nominate White House domestic policy adviser Heidi Overton to lead the Food and Drug Administration. Overton, a physician who previously worked at the America First Policy Institute, currently serves as deputy domestic policy director. If confirmed by the Senate, she would oversee an agency that has faced massive layoffs, high-level turnover, and political pressure on issues like vaccines, peptides, and flavored vapes. Former FDA Commissioner Marty Makary resigned in spring 2026 after pressure from the administration. Overton has supported Trump's executive order to stagger childhood immunizations, drawing criticism from Sen. Bill Cassidy, who questioned her commitment to science. Health and Human Services Secretary Robert F. Kennedy Jr. endorsed the pick. Overton also celebrated the Supreme Court's 2022 decision overturning Roe v. Wade.
Trump picks White House adviser Overton to head FDA
President Donald Trump announced he will nominate White House domestic policy adviser Heidi Overton to lead the Food and Drug Administration. If confirmed by the Senate, Overton would oversee an agency that has faced massive layoffs, high-level turnover, and political pressure on issues like vaccines, peptides, and flavored vapes. Former FDA Commissioner Marty Makary resigned earlier in 2026 after pressure from the administration. Overton currently serves as White House deputy domestic policy director and has appeared alongside Trump for health policy announcements. She previously worked at the America First Policy Institute, a Trump-aligned think tank, where she served as chief policy officer. Overton holds a medical degree from University of New Mexico and a Ph.D. in clinical research. She has authored articles against medication abortion and gender-affirming surgeries for children, and celebrated the Supreme Court's overturning of Roe v. Wade in 2022.
Trump picks White House adviser Overton to head FDA
President Donald Trump announced he will nominate White House domestic policy adviser Heidi Overton to lead the Food and Drug Administration. If confirmed by the Senate, Overton would oversee an agency that has faced massive layoffs, high-level turnover, and political pressure on regulatory issues like vaccines, peptides, and flavored vapes. Overton currently serves as White House deputy domestic policy director and has appeared alongside Trump for health policy announcements. She previously worked at the America First Policy Institute, a Trump-aligned think tank. Former FDA Commissioner Marty Makary resigned in spring 2026 after facing pressure over abortion medication and flavored vapes. The agency has been led by acting Commissioner Kyle Diamantas since May. Overton's nomination faces scrutiny from Senate HELP Committee Chair Bill Cassidy, who criticized her support for an executive order staggering childhood vaccinations, questioning her commitment to science and children's health.
Trump picks White House adviser Heidi Overton to run FDA
U.S. President Donald Trump has selected White House policy aide Dr. Heidi Overton to lead the Food and Drug Administration (FDA), according to a source familiar with the matter. If confirmed by the Senate, Overton, a physician trained at Johns Hopkins and a former America First Policy Institute fellow, will take over an agency that has lost over 3,000 staff in the past year and faces pressure to rebuild trust amid concerns of politicization. She replaces Marty Makary, who resigned in May after 13 months following clashes with White House advisers and controversies over flavored vapes, abortion pill reviews, and disputes with drugmakers. Overton recently appeared at a White House event where Trump announced an executive order to reduce the childhood vaccine schedule and split the MMR vaccine into separate shots. Acting chief Kyle Diamantas has run the agency since Makary's exit, reversing several regulatory decisions on rare-disease therapies and launching initiatives to speed up drug research.